DUBLIN–(BUSINESS WIRE)–The “Analysis Report of Artificial Intelligence in Drug Discovery Market Size, Share, and Trends by Application (Drug Optimization and Repurposing, Preclinical Testing), by Therapeutic Area, by Region and Segment Forecast , 2022-2030″ report has been added to from ResearchAndMarkets.com offer.

The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, growing at a CAGR of 29.4% from 2022 to 2030

The pandemic has made the adoption of AI more widespread in the pharmaceutical industry. AI and its associated platforms aim to improve medical imaging and diagnostics, chronic disease management, and drug design. The total number of human hours spent would be much higher compared to the AI ​​system analyzing the same data, reducing the overall cost and being a more feasible approach.

Drug optimization and redirection applications segment held the largest revenue share in 2021. AI platforms help identify drug target proteins to determine adverse events and possible side effects that the drug may have. Drug molecules can be reused to make them more effective and with minimal side effects. Drugs in a company’s portfolio can be modified and studied using AI platforms at a much faster rate to accelerate the development of new drugs.

The oncology therapeutic area segment accounted for the largest share of revenue in 2021. The majority of pharmaceutical companies are partnering with AI start-ups to optimize their cancer research, which is still uncharted territory and there is a lot to discover.

AI systems can identify cancer much earlier than a regular CT scan would tell even a fully trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to study for cancer research and drug development. Patients may be prescribed treatments tailored to their genetic makeup.

North America dominated the market in 2021. Many technology companies are now investing their money and efforts in the use of AI in pharmaceutical companies.

Companies like IBM, Microsoft and other tech giants have formed collaborations with research institutes to accelerate drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for drug development and disease understanding.

Highlights of the Artificial Intelligence in Drug Discovery Market Report

• The drug optimization and redirection application segment dominated the market and accounted for a revenue share of more than 50.0% in 2021.

• By therapeutic area, the oncology segment held the largest revenue share of more than 20.0% in 2021. The infectious disease segment is expected to register the fastest growth rate during the forecast period.

• Asia-Pacific is expected to grow at the fastest CAGR of 32.2% from 2022 to 2030. This can be attributed to the growing adoption of AI among developing countries in this region as a means of understanding diseases and to aid in drug discovery.

• North America dominated the market and accounted for a revenue share of over 55.0% in 2021. The United States is contributing significantly to the growth of the regional market as the country has been the forerunner in the technology of artificial intelligence.

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends and Scope

3.1 Market Segmentation

3.2 Artificial Intelligence in Drug Discovery Market Dynamics

3.2.1 Market Driver Analysis

3.2.2 Market Restraint Analysis

3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis

3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis

Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates and Trend Analysis

4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis

4.2 Drug optimization and reallocation

4.3 Preclinical trials

Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates and Trend Analysis

5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis

5.2 Oncology

5.3 Neurodegenerative diseases

5.4 Cardiovascular disease

5.5 Metabolic diseases

5.6 Infectious disease

Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates and Trend Analysis

6.1 Global Artificial Intelligence in Drug Discovery Market Movement Analysis, by Region

6.2 Global Artificial Intelligence in Drug Discovery Market Share, by Region, 2021 & 2030

Chapter 7 Competitive Analysis

7.1 Recent Developments and Impact Analysis, by Major Market Players

7.2 Categorization of Companies/Competitors (Key Innovators, Market Leaders, Emerging Players)

7.3. Competitive dashboard and analysis of the company’s position in the market

Chapter 8 Competitive Landscape

• IBM Watson

• exscientia

• Gns Health

• Alphabet (deep mind)

• Have benevolent

• Biosymmetry

• Eurete.

• Berg Health

• Atom

• Insitro

• Cyclic

For more information on this report, visit https://www.researchandmarkets.com/r/uzb7lm